Welcome to the Drug and Biologics Development Committee
Mission
The purpose of this committee is to provide opportunities to drug researchers, developers and service providers through collaboration, networking and education.
Events
Watch here for upcoming events!
Information
Developers
(select company name to access web site)
|
|
Research
|
Target Identification (ID) or Validation (V)
|
Compound Screening
|
Pre-IND & Regulatory Planning
|
Preclinical Testing
|
Formulation and Pilot Production
|
IND Preparation
|
Clinical Trials
(PI –III)
|
|
UO
|
DESIGNMEDIX
(Malaria, infx dz)
|
DESIGNMEDIX
(Malaria,infx dz)
|
DESIGNMEDIX
(Malaria, infx dz)
|
DESIGNMEDIX
(Malaria, infx dz)
|
NAJIT TECHNOLOGIES
(Vaccine dvlpmnt)
|
PROVIDENCE
(Oncology)
|
SIGA
(Phase 1, infx disease)
|
|
OHSU
|
SIGA
(Infx dz - biodefense)
|
SIGA
(Infx dz - biodefense)
|
SIGA
(Infx dz)
|
SIGA
(Infx dz - biodefense)
|
|
ARTIELLE
(Celiac Disease)
|
PROVIDENCE
(Phase 1-2, oncology)
|
|
PROVIDENCE
(Oncology)
|
OTRADI
(Infx dz, oncology, etc.)
|
OTRADI
(Infx dz, oncology, etc.)
|
OTRADI
(Infx dz, oncology, etc.)
|
OTRADI
(Infx dz, oncology, etc.)
|
|
|
ARTIELLE
(M.S., Phase 1)
|
|
DESIGNMEDIX
(Malaria, infx dz)
|
VIROGENOMICS
(Cancer, RSV)
|
|
KINONE (Oncology)
|
KINONE (Oncology)
|
|
|
|
SIGA
(Infx dz - biodefense)
|
|
|
UbiVac
(Cancer)
|
ARONORA (stroke, heart attack, sepsis)
|
|
|
|
OTRADI (Infx dz, oncology, etc.)
|
|
|
ARONORA (Stroke, heart attack, sepsis)
|
PROVIDENCE
(Oncology)
|
|
|
|
|
|
|
PROVIDENCE
(Oncology)
|
NAJIT TECHNOLOGIES
(Vaccine dvlpmnt)
|
|
|
|
|
|
|
NAJIT TECHNOLOGIES
(Vaccine dvlpmnt)
|
ARTIELLE
(Uveitis, Stroke)
|
|
|
|
|
|
|
IDBiopharma
(Biodefense, anti-virals)
|
NPI
(Stroke)
|
|
|
|
|
|
|
Research
|
Target Identification (ID) or Validation (V)
|
Compound Screening
|
Pre-IND & Regulatory Planning
|
Preclinical Testing
|
Formulation and Pilot Production
|
IND Preparation
|
Clinical Trials
(PI –III)
|
|
BASi
|
UO
(ID)
|
OHSU
BSR/PKCORE
|
Microrite
|
BASi
|
OHSU
BSR/PKCORE (Testing only)
|
GZP
|
BASi
(Assays and kits)
|
|
OHSU
(ID)
|
|
Phase1two3
|
OSHU
(Non-GLP)
|
SYNTHETECH
(chemistry process dvlpmnt & opt)
|
Microrite
|
CTI
(Clinical CRO)
|
|
|
|
GZP
|
GZP
(Strategic planning)
|
Lacamas Laboratories
(Chem. production)
|
Phase1two3
|
OHSU
(Clinical site)
|
|
|
|
Harris Group Inc
(Quality Systems Integration)
|
|
BASi
(Testing)
|
Harris Group Inc
(CMC/IMPD preparation)
|
SYNTHETECH
(Chemistry process dvlpmnt & opt)
|
|
|
|
|
|
Harris Group Inc
(Process and Facility design)
|
|
GZP
(Strategic planning)
|
|
|
|
|
|
|
|
Harris Group Inc
(Processes & Facility Engineering)
|
Staffing Services
Business and Legal Services
Facility Support
Regulatory Support
-
Ground Zero Pharmaceuticals
(Strategic Planning for nonclinical, CMC, Clinical; Medical Writing; submission preparation; FDA representation; Audits)
-
Harris Group Inc
(Quality Systems Integration, IND/CMC Assistance, Validation Master Planning)